Scott Berry

453 total citations
14 papers, 345 citations indexed

About

Scott Berry is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scott Berry has authored 14 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scott Berry's work include Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers) and Colorectal and Anal Carcinomas (4 papers). Scott Berry is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers) and Colorectal and Anal Carcinomas (4 papers). Scott Berry collaborates with scholars based in Canada and United States. Scott Berry's co-authors include Andrew J. Smith, Calvin Law, Frances C. Wright, Eric Winquist, T. Waldron, Himu Lukka, Kelvin Chan, Karen Spithoff, Rebecca Wong and Marko Šimunović and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and The Oncologist.

In The Last Decade

Scott Berry

14 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Berry Canada	11	208	113	103	44	40	14	345
Willemieke P.M. Dijksterhuis Netherlands	12	171 0.8×	199 1.8×	215 2.1×	40 0.9×	39 1.0×	30	463
Marianna V. Papageorge United States	9	127 0.6×	93 0.8×	120 1.2×	22 0.5×	29 0.7×	50	270
Timur Mitin United States	9	162 0.8×	58 0.5×	97 0.9×	41 0.9×	97 2.4×	30	290
Anke Rentsch Germany	10	288 1.4×	90 0.8×	89 0.9×	74 1.7×	15 0.4×	22	470
Hadi Bhurgri Pakistan	13	159 0.8×	81 0.7×	71 0.7×	25 0.6×	27 0.7×	28	394
Amanda R. Kahl United States	10	167 0.8×	79 0.7×	45 0.4×	16 0.4×	16 0.4×	33	291
Amanda C. R. K. Bos Netherlands	10	430 2.1×	200 1.8×	158 1.5×	25 0.6×	44 1.1×	16	563
Scott M. Atay United States	11	121 0.6×	90 0.8×	225 2.2×	34 0.8×	36 0.9×	49	433
S. Park South Korea	7	154 0.7×	88 0.8×	98 1.0×	27 0.6×	13 0.3×	20	311
Lamar S. McGinnis United States	10	296 1.4×	100 0.9×	152 1.5×	19 0.4×	12 0.3×	18	504

Countries citing papers authored by Scott Berry

Since Specialization

Citations

This map shows the geographic impact of Scott Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Berry more than expected).

Fields of papers citing papers by Scott Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Berry. The network helps show where Scott Berry may publish in the future.

Co-authorship network of co-authors of Scott Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Berry. A scholar is included among the top collaborators of Scott Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Berry. Scott Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ko, Y.J., et al.. (2020). A Systematic Review and Network Meta-Analysis of Second-Line Therapy in Hepatocellular Carcinoma. Current Oncology. 27(6). 300–306. 7 indexed citations

Hill, Andrea D., Thérèse A. Stukel, Longdi Fu, et al.. (2019). Trends in site of death and health care utilization at the end of life: a population-based cohort study. CMAJ Open. 7(2). E306–E315. 37 indexed citations

Clemons, Mark, Sasha Mazzarello, Gregory R. Pond, et al.. (2018). A prospective intervention to improve happiness and reduce burnout in oncologists. Supportive Care in Cancer. 27(4). 1563–1572. 7 indexed citations

Zhu, Xiaofu, et al.. (2016). A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancer. Gastric Cancer. 20(4). 646–654. 14 indexed citations

Emmenegger, Urban, Christopher M. Booth, Scott Berry, et al.. (2015). Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer. The Oncologist. 20(12). 1351–1352. 13 indexed citations

Hutton, Brian, Urban Emmenegger, Sasha Mazzarello, et al.. (2013). Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey. Journal of bone oncology. 2(3). 105–109. 15 indexed citations

Kennecke, Hagen F., Scott Berry, R.K. Wong, et al.. (2011). Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial. European Journal of Cancer. 48(1). 37–45. 53 indexed citations

Wong, Rebecca, Scott Berry, Karen Spithoff, et al.. (2010). Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice Guideline. Clinical Oncology. 22(4). 265–271. 47 indexed citations

Wright, Frances C., Calvin Law, Scott Berry, & Andrew J. Smith. (2009). Clinically important aspects of lymph node assessment in colon cancer. Journal of Surgical Oncology. 99(4). 248–255. 51 indexed citations

10.

Booth, Christopher M., George Dranitsaris, M. Corona Gainford, et al.. (2007). External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer. BMC Cancer. 7(1). 110–110. 28 indexed citations

11.

Winquist, Eric, T. Waldron, Scott Berry, et al.. (2006). Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group. BMC Cancer. 6(1). 112–112. 36 indexed citations

12.

Berry, Scott, T. Waldron, Eric Winquist, & Himu Lukka. (2006). The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials.. PubMed. 13(4). 3180–8. 21 indexed citations

13.

Mackay, Helen, Kevin G. Billingsley, Steven Gallinger, et al.. (2005). A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases. American Journal of Clinical Oncology. 28(6). 547–554. 13 indexed citations

14.

Parulekar, Wendy R., Rebecca Wong, William M. Mendenhall, et al.. (2004). Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 58(5). 1487–1495. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact